NCT01991951

Short Term Warfarin Therapy for Radiofrequency Catheter Ablation of Atrial Fibrillation

Prospective Randomized Study of Incidence of Thromboembolic and Bleeding Events According to the Period of Warfarin Use Before and After Catheter Ablation of Paroxysmal Atrial Fibrillation in Low Risk Patients

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 520 (estimated)
• Sponsor: Korea University Anam Hospital · Academic / Other
• Sex: All
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

We hypothesized that in patients with low CHADS-VASc score (2 or \< 2), there is no difference in thromboembolic or bleeding events between patients with short term warfarin therapy (2 weeks after catheter ablation) and conventional therapy (3 weeks before and 8 weeks after procedure).

Conditions

• Atrial Fibrillation

Interventions

Type	Name	Description
DRUG	warfarin

Timeline

• Start date: 2013-07-01
• Primary completion: 2015-07-01
• Completion: 2017-07-01
• First posted: 2013-11-25
• Last updated: 2013-11-25

Locations

1 site across 1 country: South Korea